Rentokil Initial plc — 2022 Form 20-F
Reporting period: Fiscal year ended December 31, 2022. This is an annual report, not a standalone fourth-quarter filing; the text does not provide a clear Q4-only financial breakdown. Figures below are in pounds sterling unless stated otherwise.
Business context and reporting period
Rentokil provides pest control, hygiene and wellbeing, and France workwear services across 71 countries. The major event in 2022 was the October 12 acquisition of Terminix, expanding the Group’s North American pest-control business. The Group reports under IFRS as issued by the IASB and UK-adopted International Accounting Standards.
Key financial metrics
| Metric | 2022 | 2021 | Change / context |
|---|---|---|---|
| Revenue | £3,714m | £2,957m | Up 25.6%; includes Terminix from October 12 |
| Organic revenue growth | 6.6% excluding disinfection; 4.2% including disinfection | 7.0%; 2.9%, respectively | Growth excluding disinfection eased slightly |
| Adjusted operating profit | £571m | £442m | Adjusted margin 15.4%, versus 14.9% |
| Reported operating profit | £317m | £347m | Down 8.6%; reported margin 8.5%, versus 11.7% |
| Profit before tax | £296m | £325m | Down 8.9% |
| Profit for the year | £232m | £263m | Down 11.8% |
| Basic / adjusted EPS | 11.57p / 21.34p | 14.16p / 18.07p | Reported EPS fell; adjusted EPS rose |
| Net cash from operating activities | £600m | £563m | Up £37m |
| Free cash flow | £374m | £353m | Up £21m |
| Net debt | £3,296m | £1,285m | Includes lease liabilities and debt-related derivatives |
| Liquidity headroom | £1,694m | Not stated here | £827m available RCF commitments plus £867m unrestricted cash |
At year-end, balance-sheet cash and cash equivalents were £2,170m, including cash offset by overdrafts in the cash-flow presentation. Total assets were £11,922m and total equity was £4,098m. The Group reported aggregate outstanding indebtedness of approximately £3.3bn. It had no debt maturities falling due in 2023; its £1.0bn revolving credit facility was undrawn.
Material changes versus the prior year
- Terminix generated £354m of revenue and a £6m operating loss from acquisition through year-end. Its acquisition consideration was £4,110m; total consideration for all 53 acquired businesses was £4,369m.
- Reported operating profit included £136m of one-off and adjusting costs, including £68m of Terminix transaction fees and £62m of Terminix integration costs. Amortisation and impairment of intangible assets was £118m, versus £74m in 2021.
- Adjusted operating profit increased, but reported operating profit and net profit declined, reflecting the acquisition-related items and higher amortisation. Finance income included a £22m fair-value gain on hedge ineffectiveness and a £22m hyperinflation accounting adjustment.
- Pest Control revenue rose to £2,695m from £1,952m; Hygiene & Wellbeing revenue was £821m versus £832m; France Workwear revenue was £192m versus £166m.
- Cash outflow for acquisitions, net of acquired cash and including current- and prior-period acquisitions, was £1,018m, compared with £463m in 2021. Financing raised £2,383m of new debt and repaid £844m.
Outlook, risks, contingencies and unusual items
- The filing text does not provide a clear numeric 2023 revenue or profit guidance figure. Management states the Group has sufficient liquidity for at least 12 months from approval of the financial statements, including under severe downside scenarios.
- Management identifies acquisition integration and synergy delivery, inflation and cost pass-through, labour availability, supply-chain disruption, economic weakness, cybersecurity, regulation, foreign exchange and interest rates as key risks.
- Terminix brought a £303m termite damage claims provision at December 31, 2022, down from £335m at acquisition. Management highlights estimation uncertainty in future claim rates and costs, litigation, customer churn and discount rates. The filing also describes Mississippi litigation concerning Terminix practices; its outcome could not be predicted.
- Goodwill was £5,116m, including £2,878m for the US Terminix cash-generating unit. The Group recorded £22m of goodwill impairment during 2022; acquisition-related valuations and future impairment remain sensitive to assumptions.
- Disclosure controls and procedures were deemed ineffective because of material weaknesses in internal control over financial reporting. The weaknesses included insufficient technical accounting resources, incomplete segregation-of-duties procedures and deficiencies in IT controls. Remediation was in progress and had not yet been tested for effectiveness.
- The Group reported £3,296m net debt and floating-rate exposure through the $700m term loan. It targets an S&P investment-grade BBB rating; S&P affirmed the rating following the Terminix acquisition.
- The proposed 2022 final dividend was 5.15p per share, subject to shareholder approval. A £130m proposed dividend was not recognised as a year-end liability.
Most important facts for investors to verify
- Review the Annual Report 2022 disclosures incorporated by reference for full 2022-versus-2021 operating review, liquidity and cash-flow discussion, and risk details.
- Track Terminix integration, realised synergies, retention and performance against the acquisition assumptions; distinguish acquired growth from organic performance.
- Assess the movement and key sensitivities of the £303m termite claims provision, including litigation developments and claims experience.
- Monitor debt, refinancing and interest-rate exposure, and confirm the basis for reported liquidity headroom and net debt.
- Check remediation and testing of the disclosed internal-control weaknesses, particularly given the filing’s reference to past financial-statement restatements.
- Confirm approval and payment of the proposed final dividend and review any subsequent disclosures or guidance; the filing reports no significant post-balance-sheet events through its stated reporting.